z-logo
open-access-imgOpen Access
Anlotinib inhibits the proliferation and induces apoptosis by inactivating the AKT pathway in androgen receptor-negative prostate cancer cells
Author(s) -
Yan Xu,
Jie Zheng,
Zhi-Ying Ye
Publication year - 2022
Publication title -
neoplasma
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.628
H-Index - 50
eISSN - 1338-4317
pISSN - 0028-2685
DOI - 10.4149/neo_2022_220624n661
Subject(s) - du145 , protein kinase b , apoptosis , cell growth , annexin , androgen receptor , lncap , cancer research , dapi , prostate cancer , pi3k/akt/mtor pathway , chemistry , biology , microbiology and biotechnology , medicine , cancer , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here